Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering lineage-relevant gene regulatory networks during endoderm formation by InPheRNo-ChIP. | Brief Bioinform | 2024 | 39535258 | PubTator, text mining | PubMed |
| SOX17 expression in ovarian clear cell carcinoma. | J Ovarian Res | 2024 | 39529086 | PubTator, text mining | PubMed |
| The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2024 | 39518079 | PubTator, text mining | PubMed |
| SOX17 expression in tumor-penetrating vessels in relation to CD8+ T-cell infiltration in cancer stroma niches. | Thorac Cancer | 2024 | 39385307 | PubTator, text mining | PubMed |
| Early human development and stem cell-based human embryo models. | Cell Stem Cell | 2024 | 39366361 | PubTator, text mining | PubMed |
| SOX17 expression in tumor endothelial cells in colorectal cancer and its association with favorable outcomes in patients. | Pathol Res Pract | 2024 | 39342888 | PubTator, text mining | PubMed |
| mTOR activity paces human blastocyst stage developmental progression. | Cell | 2024 | 39332412 | PubTator, text mining | PubMed |
| Marmoset and human trophoblast stem cells differ in signaling requirements and recapitulate divergent modes of trophoblast invasion. | Cell Stem Cell | 2024 | 39321797 | PubTator, text mining | PubMed |
| Reactivation of SOX17 Program as Immune-Evasion Mechanism in Early Colorectal Cancer Development. | N Engl J Med | 2024 | 39321383 | PubTator, text mining | PubMed |
| The dual role of SOX17 in the occurrence and development of early colorectal cancer. | Mol Biomed | 2024 | 39279027 | PubTator, text mining | PubMed |
| SOX17 expression in mesonephric-like adenocarcinomas and mesonephric remnants/hyperplasia of the female genital tract: Expanding its utility as a Müllerian biomarker. | Histopathology | 2024 | 39245863 | PubTator, text mining | PubMed |
| SOX17-mediated immune evasion in early colorectal cancer: From pre-malignant adaptation to tumor progression. | Acta Pharm Sin B | 2024 | 39220885 | PubTator, text mining | PubMed |
| Overlapping peri-implantation phenotypes of ZNHIT1 and ZNHIT2 despite distinct functions during early mouse development†. | Biol Reprod | 2024 | 39194072 | PubTator, text mining | PubMed |
| Neighborhood-level deprivation and survival in lung cancer. | BMC Cancer | 2024 | 39107707 | PubTator, text mining | PubMed |
| Fasudil and viscosity of gelatin promote hepatic differentiation by regulating organelles in human umbilical cord matrix-mesenchymal stem cells. | Stem Cell Res Ther | 2024 | 39075621 | PubTator, text mining | PubMed |
| Evaluation of Host Gene Methylation as a Triage Test for HPV-Positive Women-A Cohort Study. | J Low Genit Tract Dis | 2024 | 39058311 | PubTator, text mining | PubMed |
| SOX17 orchestrates immune evasion in early colorectal adenomas and cancers. | Immunology | 2024 | 39039976 | PubTator, text mining | PubMed |
| Utility of immunocytochemistry in diagnosing abdominopelvic washings from patients undergoing radical surgery for endometrial cancer. | Cytojournal | 2024 | 38989296 | PubTator, text mining | PubMed |
| ZBTB7A regulates LncRNA HOTAIR-mediated ELAVL1/SOX17 axis to inhibit malignancy and angiogenesis in endometrial carcinoma. | J Cancer Res Clin Oncol | 2024 | 38981872 | PubTator, text mining | PubMed |
| Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer. | Exp Hematol | 2024 | 38969020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=11